Most of the people who stand to benefit from genetic counselor services, such as...
The CEOs of some 300 publicly traded health care companies combined to make $4 b...
The recent case of a woman who became sick with a life-threatening disease short...
First Opinion, STAT’s platform for opinion and perspective essays, welcomes subm...
U.S. regulators on Wednesday approved the first treatment for an ultra-rare dise...
A federal appeals court on Wednesday ruled to restrict access to the abortion pi...
The strongest identified single genetic risk factor for schizophrenia turns out ...
The recall impacts Philips’ Trilogy Evo ventilators, which are used primarily in...
In a rare move, the FDA has threatened to fine a company for failing to report c...
Chinese pharmaceutical companies are developing domestic versions of “miracle” w...
To families whose boys just turned 6, putting them over the line for Sarepta's g...
The proportion of cases found in migrants to Florida has decreased significantly...
Gilead Sciences has entered into partnerships with Tentarix for the development ...
Bluebird bio eyes hattrick of gene therapy approvals, with a PDUFA date for sick...
The merger will be finalised today, transforming the businesses into a single co...
Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PD...
